ENTITY
Neuren Pharmaceuticals

Neuren Pharmaceuticals (NEU AU)

41
Analysis
Health CareAustralia
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company. The Company researches neurological and metabolic disorders.
more
21 Mar 2023 18:04

Quiddity Leaderboard-​​​​​​​​​​​ASX Jun 23: OZ Minerals Replacements and Other Changes

Seven Group Holdings (SVW AU) or Chorus Ltd (CNU NZ) could replace OZL in ASX 100 and Bellevue Gold (BGL AU) or Neuren Pharmaceuticals (NEU AU)...

Share
bullishPolyNovo Ltd
15 Mar 2023 07:03

Australia: S&P/​ASX, REMX, GDXJ, MVA, MVW, Other Flows on Friday

Implementation of the S&P/ASX, REMX, GDXJ, MVA and other indices take place at the close on Friday. There will be a lot of passive flow going...

Logo
452 Views
Share
bullishBellevue Gold
06 Mar 2023 04:18

OZ Minerals (OZL AU): Scheme Meeting in April; Potential S&P/ASX Changes

OZL's acquisition by BHP is nearly a done deal. Passive trackers will sell 18.24m shs (A$509m; 9.6x ADV) of OZL on the last trading day. There will...

Logo
446 Views
Share
09 Sep 2022 08:00Issuer-paid

Neuren Pharmaceuticals Ltd - On the Cusp of Commercialisation

Neuren Pharmaceuticals Ltd On the cusp of commercialisation Neuren Pharmaceuticals Ltd (ASX:NEU) is a clinical-stage drug company focused...

Share
04 Sep 2022 22:04

S&P ASX Sep 22 Rebal: Decent Impacts but Avoid Short Buildup

The Top 10 ADDs & DELs have average impacts of +12.7 and -11.2 days to trade respectively. Some DELs names have significant short buildup.

Share
x